@article{2f14b4ee406947fc8c2dbf35f462e26f,
title = "COVID-19 vaccine strategies must focus on severe disease and global equity",
note = "Funding Information: All authors are members of WHO's Strategic Advisory Group of Experts on Immunization (SAGE). This paper synthesises data discussed by and contributed to by all authors and on which the views expressed are based. These views do not represent an official position or recommendation of SAGE or WHO. AJP has received grants from the Medical Research Council, the Bill & Melinda Gates Foundation, the European Commission, Gavi the Vaccine Alliance, and AstraZeneca to his university. He is chair of the UK Department of Health and Social Care's Joint Committee on Vaccination and Immunisation but does not participate in policy decisions on COVID-19 vaccines. He is a member of WHO's SAGE group and is an National Institute for Health Research senior investigator. He is chief investigator on COVID-19 vaccine clinical trials done by Oxford University, Oxford, UK, funded by National Institute for Health Research. KM and PBM serve on a data safety monitoring board for Novavax COVID-19 vaccines. HN serves on a data safety monitoring board for Oxford University on ComCov studies. She is secretary of the National Immunisation Technical Advisory Group of Finland, chair of the WHO SAGE COVID-19 working group, and vice chair of the WHO SAGE group. KMN receives grants from Pfizer and National Institutes of Health for involvement in COVID-19 vaccine trials. IJ has received grants to his institution from Coalition for Epidemic Preparedness Innovations and the Bill & Melinda Gates Foundation for studies related to COVID-19. SAM has received grants to his institution from Pfizer, Minervax, and GlaxoSmithKline for group B streptococcal vaccine studies, from the Bill & Melinda Gates Foundation for multiple studies, and from Novavax for a co-funded COVID-19 study. All other authors declare no competing interests. ",
year = "2022",
month = jan,
day = "22",
doi = "10.1016/S0140-6736(21)02835-X",
language = "English",
volume = "399",
pages = "406--410",
journal = "The Lancet",
issn = "0140-6736",
publisher = "Elsevier Limited",
number = "10322",
}
